Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

anti-PSMA monoclonal antibody MLN591-DM1 immunoconjugate MLN2704

An immunoconjugate that consists of a humanized monoclonal antibody (MLN591), directed against prostate-specific membrane antigen linked to a maytansinoid (DM1). The monoclonal antibody moiety of MLN2704 binds to tumor cells expressing prostate-specific membrane antigen; MLN274 is then internalized into the tumor cell where the DM1 maytansinoid moiety binds to tubulin and inhibits tubulin polymerization and microtubule assembly, resulting in a disruption of microtubule activity and cell division, and cell death.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:DM1-conjugated monoclonal antibody MLN591
maytansinoid -1 conjugated with MLN591 monoclonal antibody
Code name:MLN591DM1
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search